Genomic imbalances in the progression of endocrine pancreatic tumors

Genes Chromosomes and Cancer

Volumn 32, Issue 4, 2001, Pages 364-372

  Zhao, Jianming ^a   Moch, Holger ^b   Scheidweiler, Alexander F ^a   Baer, Angela ^a   Schffer, Alejandro A ^c   Speel, Ernst J M ^a   Roth, Jrgen ^a   Heitz, Philipp U ^a   Komminoth, Paul ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CHROMOSOMAL LOCALIZATION; CHROMOSOME 10P; CHROMOSOME 11P; CHROMOSOME 12Q; CHROMOSOME 14Q; CHROMOSOME 21Q; CHROMOSOME 2P; CHROMOSOME 2Q; CHROMOSOME 3P; CHROMOSOME 3Q; CHROMOSOME 4; CHROMOSOME 5P; CHROMOSOME 5Q; CHROMOSOME 6Q; CHROMOSOME 7; CHROMOSOME LOSS; CONTROLLED STUDY; FEMALE; GENOME; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; METASTASIS; PANCREAS ISLET CELL TUMOR; PRIORITY JOURNAL; SCHOOL CHILD;

ADENOMA, ISLET CELL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELIC IMBALANCE; CHILD; CLONE CELLS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PANCREATIC NEOPLASMS; PROBABILITY;

EID: 0035172596     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.1201     Document Type: Article

References (28)

1. Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors
2. Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization
3. Deletion mapping of endocrine tumors localizes a second tumor suppressor gene on chromosome band 11q13
4. Positional cloning of the gene for multiple endocrine neoplasia-type 1
5. Gastrinomas demonstrate amplification of the HER-2/neu proto-oncogene
6. Somatostatin receptor scintigraphy: Its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study
7. Mutations and allelic deletions of the MENI gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregu: Neoplasms
8. Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors
9. Genetic alterations in primary bladder cancers and their metastases
10. Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1
11. Pancreatic endocrine tumors: Recent advances
12. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer
13. Identification of the von Hippel-Lindau disease tumor suppressor gene
14. Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: Diagnostic and management recommendations
15. Prognostic factors in patients with endocrine tumours of the duodenopancreatic area
16. Current approach to the management of tumoral process in patients with gastrinoma
17. Genetic alterations in primary breast cancers and their metastases: Direct comparison using modified comparative genomic hybridization
18. The pl6INK4a/CDKN2A tumor suppressor and its relatives
19. Histological typing of endocrine tumors
20. Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization
21. Benign and malignant gastrinoma
22. Chromosomal alterations in human pancreatic endocrine tumors
23. Comparative genomic hybridization analysis of sporadic neuroendocrine tumors of the digestive system
24. Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences
25. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: A prospective long-term study
26. Chromosomal imbalances in non-invasive papillary bladder neoplasms (pTa)
27. Somatic mutations of the MEN tumor suppressor gene in sporadic gastrinomas and insulinomas
28. Gastrinoma: Factors influencing prognosis